admin

Slowly but surely, it looks like the answer to that question is yes—for medicinal purposes, at least. As marijuana becomes more accepted by the law and society at large in the United State, the major professional sports have been moving towards a more permissive and open direction towards marijuana use, albeit at a glacial pace. […]

by

This article originally appeared on VICE UK.On Wednesday, Colombian president Juan Manuel Santos announced that his country’s police force had seized 12 tons of cocaine—supposedly the most ever confiscated in one sitting in the history of the country. Police say the drugs belonged to the elusive Dario Antonio Usuga, a.k.a. “Otoniel”—head of the Gulf Clan, […]

by

JERUSALEM, Nov. 15, 2017 /PRNewswire/ — Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. “The third quarter was truly transformational for Intec Pharma.  We advanced our clinical development programs and are continuing to move forward with our pivotal Phase 3 trial in Parkinson’s […]

by

(MENAFN Editorial) VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:) (“Harvest One”) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm”) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL”) in Israel using Satipharm’s proprietary GelpellR technology have been published. The […]

by

VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:HVST) (“Harvest One“) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm“) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL“) in Israel using Satipharm’s proprietary GelpellR technology have been published. The article “Single-Dose […]

by

JERUSALEM, Nov. 15, 2017 /PRNewswire/ — Intec Pharma LTD (NASDAQ: NTEC) (TASE: NTEC) today announced its third quarter 2017 financial results and provided a corporate update. “The third quarter was truly transformational for Intec Pharma.  We advanced our clinical development programs and are continuing to move forward with our pivotal Phase 3 trial in Parkinson’s […]

by

VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSX-V:HVST) (“Harvest One“) through its wholly owned Swiss Subsidiary Satipharm AG (“Satipharm“) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by PhytoTech Therapeutics (“PTL“) in Israel using Satipharm’s proprietary GelpellR technology have been published. The article “Single-Dose […]

by

“The third quarter was truly transformational for Intec Pharma.  We advanced our clinical development programs and are continuing to move forward with our pivotal Phase 3 trial in Parkinson’s Disease. Additionally, we enhanced our organizational capabilities to fully develop and commercialize the Accordion Pill, taking us another step closer to our goal of becoming a […]

by

Perth, Nov 16, 2017 AEST (ABN Newswire) – MMJ PhytoTech Limited (ASX:MMJ) (“MMJ” or “the Company”) is pleased to advise that results from the Phase 1 Clinical Trial undertaken by MMJ’s wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd (“PTL”) have been published. The article “Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation […]

by

Councilmember Dunn, Enumclaw Mayor Reynolds join in presenting first tickets Councilmember Reagan Dunn is joined by twins Cooper and Quinn Mansanarez, the first two people to enter the 2017 King County Fair!”(l-r) Washington State Representative Morgan Irwin, Councilmember Dunn, Bert the Salmon, Enumclaw Mayor Liz Reynolds, Scoop the Dog, and twins Quinn and Cooper Mansanarez […]

by

DEVON, Pa., Nov. 14, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments, today reported financial results for the third quarter ended September 30, 2017 and provided an overview of recent operational highlights. “We announced important data during the third quarter, […]

by

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company“) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm“), is pleased to advise that it’s Melbourne-based distribution partner, HL Pharma Pty Ltd (“HL Pharma”), has commenced distribution of Satipharm’s Gelpell-CBD™ capsules to approved patients in Australia. […]

by

DEVON, Pa., Nov. 14, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative pharmaceutically-produced transdermal cannabinoid treatments, today reported financial results for the third quarter ended September 30, 2017 and provided an overview of recent operational highlights. “We announced important data during the third quarter, […]

by

VANCOUVER, British Columbia, Nov. 14, 2017 (GLOBE NEWSWIRE) — Harvest One Cannabis Inc. (TSXV:HVST) (“Harvest One” or the “Company“) through its wholly owned Swiss subsidiary, Satipharm AG (“Satipharm“), is pleased to advise that it’s Melbourne-based distribution partner, HL Pharma Pty Ltd (“HL Pharma”), has commenced distribution of Satipharm’s Gelpell-CBD™ capsules to approved patients in Australia. […]

by